myirislogo
29 November, 2014 04:15 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 321.45 5.10
Tata Motors 532.95 2.78
Tata Stl 473.30 2.78
Bhel 283.20 0.07
Reliance 990.85 0.37
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Suven Life Sciences Limited
Suven Life Sciences Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:530239NSE:SUVENBloomberg:SVLS@INReuters:SUVP.BO
Market Lot: 1Face Value: 1ISIN Demat: INE495B01038
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
03-NOV-14 Suven Life Sciences today informed that their NCE SUVN-3031 has commenced Phase 1 clinical trial in USA. SUVN-G3031-A potent, selective, brain penetrant and orally active Histamine H3 antagonist for the treatment of cognitive dysfunction associated with Alzheimer's Disease, 13-OCT-14 Suven Life Sciences, a biopharmaceutical company, announces today that its drug discovery portfolio which has expanded into several new therapeutic are...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Suven gains after securing two product patents  -IRIS 13-Oct-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 1415.325103.122578.85
Other Income10.7930.3010.43
Total Income1426.115133.422589.28
Cost of goods sold836.502912.542046.99
OPBDIT589.612220.88542.29
PAT347.381441.58308.40
Gross Block---
Equity capital116.83116.83116.83
EPS (Rs.)-12.342.64
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-1.78 - 6.765.09 - 13.35
Debt / Equity (x)---
Operating margin (% of OI)41.343.320.9
Net margin (% of OI)24.428.111.9
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
SDE Serene Chambers
Road No 5
Banjara Hills
Hyderabad
Andhra Pradesh-500 034
PHONE
(040) 2354 1142/ 3311
FAX
(040) 2354 1152
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer